126 related articles for article (PubMed ID: 36988426)
1. Prescribing and deprescribing trends in schizophrenia: An overview of inpatients in Belgium and in the Canadian province of Québec.
Lagreula J; Dagenais-Beaulé V; de Timary P; Elens L; Dalleur O
Basic Clin Pharmacol Toxicol; 2023 Dec; 133(6):691-702. PubMed ID: 36988426
[TBL] [Abstract][Full Text] [Related]
2. Antipsychotic polypharmacy and clozapine prescribing patterns: evolution and correlates before and after a psychiatric hospitalisation.
Lagreula J; de Timary P; Elens L; Dalleur O
Ther Adv Psychopharmacol; 2022; 12():20451253221112587. PubMed ID: 36051501
[TBL] [Abstract][Full Text] [Related]
3. Antipsychotic Adherence and Rehospitalization in Schizophrenia Patients Receiving Oral Versus Long-Acting Injectable Antipsychotics Following Hospital Discharge.
Marcus SC; Zummo J; Pettit AR; Stoddard J; Doshi JA
J Manag Care Spec Pharm; 2015 Sep; 21(9):754-68. PubMed ID: 26308223
[TBL] [Abstract][Full Text] [Related]
4. Impact of a Caffeine Restriction Policy on Inpatients With Schizophrenia: A Pre-Post Comparison Using Electronic Health Records.
Lagreula J; Ferraiolo M; De Timary P; Delatte B; Elens L; Hermans E; Dalleur O
J Clin Psychopharmacol; 2023 Mar-Apr 01; 43(2):167-170. PubMed ID: 36825857
[TBL] [Abstract][Full Text] [Related]
5. [Pharmaco-epidemiological study on antipsychotic drug prescription in French Psychiatry: Patient characteristics, antipsychotic treatment, and care management for schizophrenia].
Brunot A; Lachaux B; Sontag H; Casadebaig F; Philippe A; Rouillon F; Cléry-Melin P; Hergueta T; Llorca PM; Moreaudefarges T; Guillon P; Lebrun T
Encephale; 2002; 28(2):129-38. PubMed ID: 11972139
[TBL] [Abstract][Full Text] [Related]
6. A Prescription for Deprescribing Antipsychotics: Managing Polypharmacy in Schizophrenia.
Paudel S; Vyas CM; Stern TA
Prim Care Companion CNS Disord; 2020 Dec; 22(6):. PubMed ID: 33351291
[TBL] [Abstract][Full Text] [Related]
7. Impact of deprescribing AChEIs on aggressive behaviors and antipsychotic prescribing.
Niznik JD; Zhao X; He M; Aspinall SL; Hanlon JT; Nace D; Thorpe JM; Thorpe CT
Alzheimers Dement; 2020 Apr; 16(4):630-640. PubMed ID: 32052930
[TBL] [Abstract][Full Text] [Related]
8. Risk Factors, Incidence, and Outcomes of Neuroleptic Malignant Syndrome on Long-Acting Injectable vs Oral Antipsychotics in a Nationwide Schizophrenia Cohort.
Guinart D; Taipale H; Rubio JM; Tanskanen A; Correll CU; Tiihonen J; Kane JM
Schizophr Bull; 2021 Oct; 47(6):1621-1630. PubMed ID: 34013325
[TBL] [Abstract][Full Text] [Related]
9. Deprescribing opportunities for elderly inpatients in an academic, safety-net health system.
Bredhold BE; Deodhar KS; Davis CM; DiRenzo BM; Isaacs AN; Campbell NL
Res Social Adm Pharm; 2021 Mar; 17(3):541-544. PubMed ID: 32402730
[TBL] [Abstract][Full Text] [Related]
10. Patterns of discontinuation of atypical antipsychotics in the province of Québec: A retrospective prescription claims database analysis.
Moisan J; Grégoire JP
Clin Ther; 2010; 32 Suppl 1():S21-31. PubMed ID: 20152549
[TBL] [Abstract][Full Text] [Related]
11. [Initiating an antipsychotic drug treatment for schizophrenia: the situation in Quebec, Canada, from 1998 to 2006].
Carrier JD; Blais L; Cohen A; Courteau J; Roberge P; Larouche A; Grignon S; Fleury MJ; Lesage A; Demers MF; Roy MA; Delorme A; Vanasse A
Sante Ment Que; 2017; 42(1):85-103. PubMed ID: 28792563
[TBL] [Abstract][Full Text] [Related]
12. Compliance with refilling prescriptions for atypical antipsychotic agents and its association with the risks for hospitalization, suicide, and death in patients with schizophrenia in Quebec and Saskatchewan: a retrospective database study.
Ward A; Ishak K; Proskorovsky I; Caro J
Clin Ther; 2006 Nov; 28(11):1912-21. PubMed ID: 17213012
[TBL] [Abstract][Full Text] [Related]
13. Patterns of drug prescribing in inpatients with first episode of schizophrenia spectrum disorder: The role of guidelines
.
Stašević M; Stašević Karličić I; Grgurević A; Divac N
Int J Clin Pharmacol Ther; 2020 Jul; 58(7):387-394. PubMed ID: 32352369
[TBL] [Abstract][Full Text] [Related]
14. Attitude towards deprescribing and its association with frailty and complexity of medication regimen: A survey of older inpatients in a district health board in New Zealand.
Mohammed MA; Harrison J; Milosavljevic A; Chan AHY
BMC Geriatr; 2023 Mar; 23(1):166. PubMed ID: 36959598
[TBL] [Abstract][Full Text] [Related]
15. Optimizing Practices, Use, Care and Services-Antipsychotics (OPUS-AP) in Long-term Care Centers in Québec, Canada: A Strategy for Best Practices.
Cossette B; Bruneau MA; Couturier Y; Gilbert S; Boyer D; Ricard J; McDonald T; Labarre K; Déry V; Arcand M; Rodrigue C; Rhéaume AA; Moreault S; Allard C; Pépin MÉ; Beauchet O;
J Am Med Dir Assoc; 2020 Feb; 21(2):212-219. PubMed ID: 31669289
[TBL] [Abstract][Full Text] [Related]
16. Underprescribing of clozapine and unexplained variation in use across hospitals and regions in the Canadian province of Québec.
Latimer E; Wynant W; Clark R; Malla A; Moodie E; Tamblyn R; Naidu A
Clin Schizophr Relat Psychoses; 2013 Apr; 7(1):33-41. PubMed ID: 23367500
[TBL] [Abstract][Full Text] [Related]
17. New Antipsychotic Prescribing Continued into Skilled Nursing Facilities Following a Heart Failure Hospitalization: a Retrospective Cohort Study.
Riester MR; Goyal P; Jiang L; Erqou S; Rudolph JL; McGeary JE; Rogus-Pulia NM; Madrigal C; Quach L; Wu WC; Zullo AR
J Gen Intern Med; 2022 Oct; 37(13):3368-3379. PubMed ID: 34981366
[TBL] [Abstract][Full Text] [Related]
18. Continuity of care among patients newly initiated on second-generation oral or long-acting injectable antipsychotics during a schizophrenia-related inpatient stay.
Patel C; Pilon D; Morrison L; Holiday C; Lafeuille MH; Lefebvre P; Benson C
Curr Med Res Opin; 2023 Aug; 39(8):1157-1166. PubMed ID: 37461233
[TBL] [Abstract][Full Text] [Related]
19. [Cost-effectiveness analysis of schizophrenic patient care settings: impact of an atypical antipsychotic under long-acting injection formulation].
Llorca PM; Miadi-Fargier H; Lançon C; Jasso Mosqueda G; Casadebaig F; Philippe A; Guillon P; Mehnert A; Omnès LF; Chicoye A; Durand-Zaleski I
Encephale; 2005; 31(2):235-46. PubMed ID: 15959450
[TBL] [Abstract][Full Text] [Related]
20. Facilitators and Barriers Influencing Antipsychotic Medication Prescribing and Deprescribing Practices in Critically Ill Adult Patients: a Qualitative Study.
Jaworska N; Krewulak KD; Schalm E; Niven DJ; Ismail Z; Burry LD; Leigh JP; Fiest KM
J Gen Intern Med; 2023 Aug; 38(10):2262-2271. PubMed ID: 37072535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
